Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 10Pancreatic Neoplasms 4Neoplasms 4Lung Neoplasms 4Hematologic Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Sarcoma 2Recurrence 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Multiple Myeloma 2Melanoma 2Uterine Cervical Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Radiodermatitis 1Papillomavirus Infections 1Ovarian Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, Mantle-Cell 1Lymphedema 1Localized Prostate Carcinoma 1

Interventions

fludarabine phosphate 13Cyclophosphamide 13fludarabine 10Whole-Body Irradiation 10Melphalan 10Tacrolimus 9Busulfan 9Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Alemtuzumab 5Cyclosporine 4Antilymphocyte Serum 4Stem Cell Transplantation 3Methotrexate 3Granulocyte Colony-Stimulating Factor 3thymoglobulin 2sargramostim 2Thiotepa 2Rituximab 2Methylprednisolone 2Filgrastim 2posaconazole 1methanesulfonic acid 1merphos 1ibrutinib 1Transplantation, Homologous 1Transplantation 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia, Aplastic × Practice Guidelines as Topic × Clear all
NCT04439006 2023-12-26

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
10 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡